Chase Packaging (WHLT) 10-Q15 May 242024 Q1 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 10, 2024
Cover [Abstract]
Entity Registrant Name	Chase Packaging Corporation
Entity Central Index Key	0001025771
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		61,882,172
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	0-21609
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	93-1216127
Entity Address Address Line 1	PO Box 126
Entity Address City Or Town	Rumson
Entity Address State Or Province	NJ
Entity Address Postal Zip Code	07760
City Area Code	732
Local Phone Number	741.1500
Entity Interactive Data Current	Yes

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 351,388	$ 388,171
TOTAL ASSETS	351,388	388,171
CURRENT LIABILITIES:
Accounts payable and accrued expenses	3,473	4,985
TOTAL CURRENT LIABILITIES	3,473	4,985
STOCKHOLDERS' EQUITY:
Preferred stock, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible preferred stock; 50,000 shares designated; no shares issued and outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, $0.00001 par value; 200,000,000 shares authorized; 62,379,759 shares issued and 61,882,172 shares outstanding at March 31, 2024 and December 31, 2023	619	619
Treasury stock, $0.00001 par value 497,587 shares at March 31, 2024 and December 31, 2023	(49,759)	(49,759)
Additional paid-in capital	8,839,367	8,839,367
Accumulated deficit	(8,442,312)	(8,407,041)
TOTAL STOCKHOLDERS' EQUITY	347,915	383,186
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 351,388	$ 388,171

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
STOCKHOLDERS' EQUITY
Preferred stock, shares par value	$ 1	$ 1
Preferred stock, shares authorized	4,000,000	4,000,000
Common stock, shares par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	62,379,759	62,379,759
Common stock, shares outstanding	61,882,172	61,882,172
Treasury stock, shares par value	$ 0.00001	$ 0.00001
Trasury Stock, shares issued	497,587	497,587
10% Series A Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
NET SALES	$ 0	$ 0
OPERATING EXPENSES:
General and administrative expense	39,137	15,839
TOTAL OPERATING EXPENSES	39,137	15,839
LOSS FROM OPERATIONS	(39,137)	(15,839)
OTHER INCOME (EXPENSE)
Interest and other income	3,866	2,353
Warrant modification expense	0	(621,810)
TOTAL OTHER INCOME (EXPENSE)	3,866	(619,457)
LOSS BEFORE INCOME TAXES	(35,271)	(635,296)
Provision for income taxes	0	0
NET LOSS	$ (35,271)	$ (635,296)
BASIC AND DILUTED LOSS PER COMMON SHARE	$ 0	$ (0.01)
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	61,882,172	61,882,172

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (Unaudited) - USD ($)	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2022		61,882,172	497,587
Balance, amount at Dec. 31, 2022	$ 440,766	$ 619	$ (49,759)	$ 8,493,917	$ (8,004,011)
Modification of warrants, expiration of 6,909,000 warrants extended to March 8, 2026	621,810	0	0	621,810	0
Net loss	(635,296)	$ 0	$ 0	0	(635,296)
Balance, shares at Mar. 31, 2023		61,882,172	497,587
Balance, amount at Mar. 31, 2023	427,280	$ 619	$ (49,759)	9,115,727	(8,639,307)
Balance, shares at Dec. 31, 2023		61,882,172	497,587
Balance, amount at Dec. 31, 2023	383,186	$ 619	$ (49,759)	8,839,367	(8,407,041)
Net loss	(35,271)	$ 0	$ 0	0	(35,271)
Balance, shares at Mar. 31, 2024		61,882,172	497,587
Balance, amount at Mar. 31, 2024	$ 347,915	$ 619	$ (49,759)	$ 8,839,367	$ (8,442,312)

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (35,271)	$ (635,296)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Warrants modification expense	0	621,810
Change in operating assets and liabilities:
Accounts payable and accrued expenses	(1,512)	3,750
Net cash used in operating activities	(36,783)	(9,736)
CASH FLOWS FROM INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES	0	0
NET DECREASE IN CASH	(36,783)	(9,736)
Cash, beginning of period	388,171	441,243
CASH, END OF PERIOD	351,388	431,507
Cash paid for:
Interest	0	0
Income taxes	$ 0	$ 0

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2024
BASIS OF PRESENTATION
BASIS OF PRESENTATION	NOTE 1 - BASIS OF PRESENTATION: Chase Packaging Corporation (“the Company”), a Delaware Corporation, previously manufactured woven paper mesh for industrial applications and polypropylene mesh fabric bags for agricultural use, and distributed agricultural packaging manufactured by other companies. Management’s plans for the Company include securing a merger or acquisition, raising additional capital, and other strategies designed to optimize shareholder value. However, no assurance can be given that management will be successful in its efforts. The failure to achieve these plans will have a material adverse effect on the Company’s financial position, results of operations, and ability to continue as a going concern. The unaudited condensed financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to provide for fair presentation and a reasonable understanding of the information presented. The unaudited condensed financial statements should be read in conjunction with the financial statements and the related notes, as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, previously filed with the SEC. In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair statement of financial position as of March 31, 2024, and results of operations and cash flows for the three months ended March 31, 2024 and 2023, as applicable, have been made. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the operating results for the full fiscal year ended December 31, 2024 or any future periods.

LIQUIDITY

LIQUIDITY	3 Months Ended
LIQUIDITY	Mar. 31, 2024
LIQUIDITY
LIQUIDITY	NOTE 2 - LIQUIDITY At March 31, 2024 and December 31, 2023, the Company had cash and cash equivalents of $351,388 and $388,171, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2024 and 2023, amounted to $35,271 and $635,296, respectively, and we had working capital of $347,915 and $383,186 at March 31, 2024 and December 31, 2023, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2024
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS: Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments that are readily convertible into cash with a remaining maturity of three months or less at the time of acquisition to be cash equivalents. The Company maintains its cash and cash equivalents balances with high credit quality financial institutions. As of March 31, 2024 and December 31, 2023, the Company had cash in insured accounts in the amount of $56,172 and $9,721, respectively, and cash equivalents (Treasury and government securities) held in financial institutions that were uninsured by Federal Deposit Insurance Corporation in the amount of $295,216 and $378,450, respectively. Income Taxes The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carry forwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured assuming enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it is more likely than not that such asset will be realized. The Company follows FASB Interpretation of “Accounting for Uncertainty in Income Taxes.” At March 31, 2024 and December 31, 2023, the Company evaluated its tax positions and did not have any unrecognized tax benefits. The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company currently has no federal or state tax examinations in progress. Accounting for Stock Based Compensation Stock-based compensation expense incurred by the Company for employees and directors is based on the employee model of ASC 718, and the fair market value of the award is measured at the grant date. Under ASC 718 employee is defined as “An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. “tax regulations.” Our consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 718 as amended by ASU 2018-07. As such, the grant date is the measurement date of an award’s fair value. Corresponding expenses for employee and non-employee services are recognized over the requisite service period, which is typically the vesting period. Treasury Stock The Company accounts for treasury stock using the cost method. There were 497,587 shares of Class A common stock held in treasury, purchased at a total cumulative cost of approximately $49,759, as of March 31, 2024 and December 31, 2023. Recently Adopted Accounting Pronouncements The FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

BASIC AND DILUTED NET LOSS PER

BASIC AND DILUTED NET LOSS PER COMMON SHARE	3 Months Ended
BASIC AND DILUTED NET LOSS PER COMMON SHARE	Mar. 31, 2024
BASIC AND DILUTED NET LOSS PER COMMON SHARE
BASIC AND DILUTED NET LOSS PER COMMON SHARE	NOTE 4 - BASIC AND DILUTED NET LOSS PER COMMON SHARE: Basic loss per common share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding. Diluted loss per share is computed by dividing the net loss by the sum of the weighted-average number of shares of common stock outstanding plus the dilutive effect of shares issuable through the exercise of common stock equivalents. We have excluded 6,909,000 common stock equivalents (warrants - Note 5) from the calculation of diluted loss per share for the three months ended March 31, 2024 and 2023, respectively, which, if included, would have an antidilutive effect.

WARRANTS AND PREFERRED STOCKS

WARRANTS AND PREFERRED STOCKS	3 Months Ended
WARRANTS AND PREFERRED STOCKS	Mar. 31, 2024
WARRANTS AND PREFERRED STOCKS
WARRANTS AND PREFERRED STOCKS	NOTE 5 - WARRANTS AND PREFERRED STOCKS: Warrants 2023 Extension of Warrant Terms The Company, acting by resolution of its Board of Directors, amended and extended the expiration date of its outstanding warrants to purchase up to 6,909,000 shares of common stock to March 7, 2026. The terms of the warrants, including the exercise price of $0.15 per share, remain in effect without modification. The warrants modification expense of $345,450 was recorded as the incremental value of the modified warrants over the unmodified warrants on the modification date. Assumptions used in the Black Scholes option-pricing model for these warrants were as follows: Average risk-free interest rate 4.66 % Average expected life-years 3 Expected volatility 182.19 % Expected dividends 0 % Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Outstanding at December 31, 2023 6,909,000 $ 0.15 2.18 Granted — — — Extended — — — Exercised — — — Forfeited/expired — — — Outstanding at March 31, 2024 6,909,000 $ 0.15 1.93 Exercisable at March 31, 2024 6,909,000 $ 0.15 1.93 As of March 31, 2024 and December 31, 2023, the average remaining contractual life of the outstanding warrants was 1.93 years and 2.18 year, respectively. The warrants will expire on March 7, 2026. The intrinsic value of the warrants at March 31, 2024 was $276,360 due to the fair market value exceeding the exercise price of the common stock. Series A 10% Convertible Preferred Stock The Company has authorized 4,000,000 shares of Preferred Stock, of which 50,000 shares have been designated as Series A 10% Convertible Preferred Stock. As of March 31, 2024 and December 31, 2023, there was no preferred stock issued or outstanding.

STOCKHOLDERS EQUITY AND STOCK-B

STOCKHOLDERS EQUITY AND STOCK-BASED COMPENSATION	3 Months Ended
STOCKHOLDERS EQUITY AND STOCK-BASED COMPENSATION	Mar. 31, 2024
STOCKHOLDERS EQUITY AND STOCK-BASED COMPENSATION
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION	NOTE 6 - STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION: At March 31, 2024 and December 31, 2023, the Company had 61,882,172 common shares outstanding. Also outstanding were warrants relating to 6,909,000 shares of common stock, all totaling 68,791,172 shares of common stock and all common stock equivalents, outstanding at March 31, 2024 and December 31, 2023. The Company did not incur any stock-based compensation or issue common or preferred stock or any other equity instruments during the three months ended March 31, 2024 and 2023.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
FAIR VALUE MEASUREMENTS	Mar. 31, 2024
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 7 - FAIR VALUE MEASUREMENTS: ASC 820, “Fair Value Measurements and Disclosure,” (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels are described below: Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company; Level 2 Inputs - Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; Level 3 Inputs - Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants. There were no transfers in or out of any level during the three months ended March 31, 2024 or 2023. Except for those assets and liabilities which are required by authoritative accounting guidance to be recorded at fair value in the Company’s balance sheets, the Company has elected not to record any other assets or liabilities at fair value, as permitted by ASC 820. No events occurred during the three months ended March 31, 2024 or 2023 which would require adjustment to the recognized balances of assets or liabilities which are recorded at fair value on a nonrecurring basis. The Company determines fair values for its investment assets as follows: Cash equivalents at fair value - the Company’s cash equivalents, at fair value, consist of money market funds - marked to market on reporting dates. The Company’s money market funds are classified within Level 1 of the fair value hierarchy since they are valued using quoted market prices from an exchange. The following tables provide information on those assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, respectively: Carrying Amount In Balance Sheet March 31, Fair Value March 31, Fair Value Measurement Using 2024 2024 Level 1 Level 2 Level 3 Assets: Treasury and government securities $ 295,216 $ 295,216 $ 295,216 $ — $ — Money market funds 56,172 56,172 56,172 — — Total Assets $ 351,388 $ 351,388 $ 351,388 $ — $ — Carrying Amount In Balance Sheet December 31, Fair Value December 31, Fair Value Measurement Using 2023 2023 Level 1 Level 2 Level 3 Assets: Treasury and government securities $ 378,450 $ 378,450 $ 378,450 $ — $ — Money market funds 9,721 9,721 9,721 — — Total Assets $ 388,171 $ 388,171 $ 388,171 $ — $ —

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2024
COMMITMENTS AND CONTINGENCIES (Note 9)
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES: The Company’s Board of Directors has agreed to pay the Company’s Chief Financial Officer an annual salary of $17,000. No other officers or directors of the Company receive cash compensation other than reimbursement of out-of-pocket expenses incurred in connection with Company business and development.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 9 - SUBSEQUENT EVENTS: On February 7, 2024, the Company signed a non-binding indication of interest to acquire the three subsidiaries of Roseville Partners, LLC, a privately owned company. The indication of interest has now expired and has not been extended. While the Company may continue discussions with Roseville, there can be no assurance or expectation that the parties will enter into definitive agreements. A press release announcing the expiration of the indication of interest was issued April 29, 2024.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Policies)	3 Months Ended
	Mar. 31, 2024
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS
Use of Estimates:	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	The Company considers all highly liquid investments that are readily convertible into cash with a remaining maturity of three months or less at the time of acquisition to be cash equivalents. The Company maintains its cash and cash equivalents balances with high credit quality financial institutions. As of March 31, 2024 and December 31, 2023, the Company had cash in insured accounts in the amount of $56,172 and $9,721, respectively, and cash equivalents (Treasury and government securities) held in financial institutions that were uninsured by Federal Deposit Insurance Corporation in the amount of $295,216 and $378,450, respectively.
Income Taxes	The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carry forwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured assuming enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it is more likely than not that such asset will be realized. The Company follows FASB Interpretation of “Accounting for Uncertainty in Income Taxes.” At March 31, 2024 and December 31, 2023, the Company evaluated its tax positions and did not have any unrecognized tax benefits. The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company currently has no federal or state tax examinations in progress.
Accounting for Stock Based Compensation	Stock-based compensation expense incurred by the Company for employees and directors is based on the employee model of ASC 718, and the fair market value of the award is measured at the grant date. Under ASC 718 employee is defined as “An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. “tax regulations.” Our consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 718 as amended by ASU 2018-07. As such, the grant date is the measurement date of an award’s fair value. Corresponding expenses for employee and non-employee services are recognized over the requisite service period, which is typically the vesting period.
Treasury Stock	The Company accounts for treasury stock using the cost method. There were 497,587 shares of Class A common stock held in treasury, purchased at a total cumulative cost of approximately $49,759, as of March 31, 2024 and December 31, 2023.
Recently Adopted Accounting Pronouncements	The FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

WARRANTS AND PREFERRED STOCKS (

WARRANTS AND PREFERRED STOCKS (Tables)	3 Months Ended
WARRANTS AND PREFERRED STOCKS (Tables)	Mar. 31, 2024
WARRANTS AND PREFERRED STOCKS
Summary of assumptions used in Black Scholes option-pricing model	Average risk-free interest rate 4.66 % Average expected life-years 3 Expected volatility 182.19 % Expected dividends 0 %
Schedule of Share-based Compensation, Warrant Options	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Outstanding at December 31, 2023 6,909,000 $ 0.15 2.18 Granted — — — Extended — — — Exercised — — — Forfeited/expired — — — Outstanding at March 31, 2024 6,909,000 $ 0.15 1.93 Exercisable at March 31, 2024 6,909,000 $ 0.15 1.93

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Mar. 31, 2024
FAIR VALUE MEASUREMENTS
Schedule of assets and liabilities measured at fair value on a recurring basis	Carrying Amount In Balance Sheet March 31, Fair Value March 31, Fair Value Measurement Using 2024 2024 Level 1 Level 2 Level 3 Assets: Treasury and government securities $ 295,216 $ 295,216 $ 295,216 $ — $ — Money market funds 56,172 56,172 56,172 — — Total Assets $ 351,388 $ 351,388 $ 351,388 $ — $ — Carrying Amount In Balance Sheet December 31, Fair Value December 31, Fair Value Measurement Using 2023 2023 Level 1 Level 2 Level 3 Assets: Treasury and government securities $ 378,450 $ 378,450 $ 378,450 $ — $ — Money market funds 9,721 9,721 9,721 — — Total Assets $ 388,171 $ 388,171 $ 388,171 $ — $ —

LIQUIDITY (Details Narrative)

LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended
LIQUIDITY (Details Narrative) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
LIQUIDITY
Net loss	$ (35,271)	$ (635,296)
Cash And Cash Equivalents	351,388		$ 388,171
Working Capital	$ 347,915		$ 383,186

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS
Cash, FDIC insured	$ 56,172	$ 9,721
Trasury Stock, shares issued	497,587	497,587
Cash equivalents, FDIC uninsured	$ 295,216	$ 378,450
Treasury stock, $0.00001 par value 497,587 shares at March 31, 2024 and December 31, 2023	$ (49,759)	$ (49,759)

BASIC AND DILUTED NET LOSS PE_2

BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details Narrative) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
BASIC AND DILUTED NET LOSS PER COMMON SHARE
Common stock share excluded from computation of earning per share	6,909,000	6,909,000

WARRANTS AND PREFERRED STOCKS_2

WARRANTS AND PREFERRED STOCKS (Details)	3 Months Ended
WARRANTS AND PREFERRED STOCKS (Details)	Mar. 31, 2024
WARRANTS AND PREFERRED STOCKS
Average risk-free interest rate	4.66%
Average expected life- years	3 years
Expected volatility	182.19%
Expected dividends	0%

WARRANTS AND PREFERRED STOCKS_3

WARRANTS AND PREFERRED STOCKS (Details 1) - Warrants [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Number of warrants/options outstanding, beginning \| shares	6,909,000
Granted \| shares	0
Extended \| shares	0
Exercised \| shares	0
Forfeited/expired \| shares	0
Exercisable \| shares	6,909,000
Number of warrants/options outstanding, ending \| shares	6,909,000
Weighted average exercise price outstanding, Beginning \| $ / shares	$ 0.15
Weighted average exercise price outstanding, extended \| $ / shares	0
Weighted average exercise price outstanding, Granted \| $ / shares	0
Weighted average exercise price outstanding, Exercised \| $ / shares	0
Weighted average exercise price outstanding, Forfeited/expired \| $ / shares	0
Weighted average exercise price outstanding, ending \| $ / shares	0.15
Weighted average exercise price outstanding, exercisable \| $ / shares	$ 0.15
Weighted average remaining contractual life outstanding, beginning	2 years 2 months 4 days
Weighted average remaining contractual life outstanding, Ending	1 year 11 months 4 days
Weighted average remaining contractual life outstanding, Exercisable	1 year 11 months 4 days

WARRANTS AND PREFERRED STOCKS_4

WARRANTS AND PREFERRED STOCKS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
WARRANTS AND PREFERRED STOCKS (Details Narrative) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Preferred stock, shares authorized	4,000,000		4,000,000
Warrants modification expense	$ 0	$ 621,810
2023 Extension of Warrant Term
Warrants to purchase common stock shares	6,909,000
Weighted average remaining contractual life outstanding	1 year 11 months 4 days		2 years 2 months 4 days
Extension of warrant terms description	amended and extended the expiration date of its outstanding warrants to purchase up to 6,909,000 shares of common stock to March 7, 2026
Exercise price of warrant, per share	$ 0.15
Expiry of warrant	Mar. 07, 2026
Intrinsic value	$ 276,360
Warrants modification expense	$ 345,450
10% Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized	50,000		50,000

STOCKHOLDERS EQUITY AND STOCKBA

STOCKHOLDERS EQUITY AND STOCKBASED COMPENSATION (Details Narrative) - shares	Mar. 31, 2024	Dec. 31, 2023
STOCKHOLDERS EQUITY AND STOCK-BASED COMPENSATION
Common stock, shares outstanding	61,882,172	61,882,172
Warrants outstanding	6,909,000	6,909,000
Total outstanding	68,791,172	68,791,172

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Inputs, Level 1 [Member]
Assets at fair value on recurring basis	$ 351,388	$ 388,171
Fair Value, Inputs, Level 2 [Member]
Assets at fair value on recurring basis	0	0
Fair Value, Inputs, Level 3 [Member]
Assets at fair value on recurring basis	0	0
Fair Value [Member]
Assets at fair value on recurring basis	351,388	388,171
Treasury and government securities [Member] \| Fair Value, Inputs, Level 1 [Member]
Assets at fair value on recurring basis	295,216	378,450
Treasury and government securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Assets at fair value on recurring basis	0	0
Treasury and government securities [Member] \| Fair Value, Inputs, Level 3 [Member]
Assets at fair value on recurring basis	0	0
Treasury and government securities [Member] \| Fair Value [Member]
Assets at fair value on recurring basis	295,216	378,450
Money markets funds [Member] \| Fair Value, Inputs, Level 1 [Member]
Assets at fair value on recurring basis	56,172	9,721
Money markets funds [Member] \| Fair Value, Inputs, Level 2 [Member]
Assets at fair value on recurring basis	0	0
Money markets funds [Member] \| Fair Value, Inputs, Level 3 [Member]
Assets at fair value on recurring basis	0	0
Money markets funds [Member] \| Fair Value [Member]
Assets at fair value on recurring basis	56,172	9,721
Carrying Value [Member]
Assets at fair value on recurring basis	351,388	388,171
Carrying Value [Member] \| Treasury and government securities [Member]
Assets at fair value on recurring basis	295,216	378,450
Carrying Value [Member] \| Money markets funds [Member]
Assets at fair value on recurring basis	$ 56,172	$ 9,721

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)	3 Months Ended
COMMITMENTS AND CONTINGENCIES (Details Narrative)	Mar. 31, 2024 USD ($)
Warrants [Member]
Annual salary	$ 17,000